Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1013993 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Graciela Juez-Castillo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Parasitología y Biomedicina "López-Neyra", CSIC, (IPBLN-CSIC), PTS Granada, Granada, Spain. Hauptthemen laut MEDLINE: Heme, Protozoan Proteins, Leishmania major, Leishmaniasis, Cutaneous. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leishmania spp. are intracellular parasites that cause leishmaniasis, a devastating disease with no effective treatment. These parasites are heme auxotrophs and must scavenge this essential cofactor from the host. Transcriptomic analysis of Leishmania major promastigotes cultured in the presence or absence of heme revealed numerous differentially expressed genes. Among those of unknown function, LHR2 ( Leishmania Heme Response-2) was the most upregulated gene in response to heme limitation. LHR2 encodes a mitochondrial hemoprotein that likely protects this organelle from elevated levels of reactive oxygen species. It is essential during the promastigote stage, and loss of a single LHR2 allele severely compromises intracellular replication and prevents the development of cutaneous leishmaniasis in mice. This essential function depends on LHR2’s ability to bind heme. Complementation studies in Saccharomyces cerevisiae revealed that LHR2 is an analogue of the yeast Dap1p, although it binds heme in a distinct manner. Importantly, LHR2 displays key structural differences from the most closely related human proteins. These findings highlight LHR2 as a critical factor in parasite survival and pathogenesis, and suggest it as a promising new target for antileishmanial drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Parasitología y Biomedicina "López-Neyra", CSIC, (IPBLN-CSIC), PTS Granada, Granada, Spain.
- Universidad El Bosque, Faculty of Engineering, Osiris and Bioaxis Research Group, Bogotá D.C., Colombia.
- Programa de Estudio y Control de Enfermedades Tropicales PECET, Faculty of Medicine, University of Antioquía, Medellín, Colombia.
- Universidad Internacional de La Rioja, Facultad de Ciencias de la Educación y Humanidades, Logroño, Spain.
- Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain.
ORCID-Profile: José M Pérez-Victoria
Zitieren
APA
Juez-Castillo, G., García-Hernández, R., Guerra-Arias, D., Vargas, P., Cabello-Donayre, M., Monteiro, J. M., Valencia-Vidal, B., Rivas, L., Andrés-León, E., Castanys, S., Orrego, L. M., & Pérez-Victoria, J. M. (2026). Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013993
Vancouver
Juez-Castillo G, García-Hernández R, Guerra-Arias D, Vargas P, Cabello-Donayre M, Monteiro JM, et al. Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1013993
BibTeX
@article{JuezCastillo2026,
author = {Juez-Castillo, Graciela and García-Hernández, Raquel and Guerra-Arias, Diego and Vargas, Paola and Cabello-Donayre, María and Monteiro, Juan M and Valencia-Vidal, Brayan and Rivas, Luis and Andrés-León, Eduardo and Castanys, Santiago and Orrego, Lina M and Pérez-Victoria, José M},
title = {Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1013993}
}
EUVIMED